SOPHARMA AD: Current report 88 buy back 10092012 ENG

opublikowano: 2012-09-10 15:45

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_88_buy_back_10092012_ENG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 88 / 2012
Date of issue: 2012-09-10
Short name of the issuer
SOPHARMA AD
Subject
Current report 88 buy back 10092012 ENG
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
The Board of Directors of SOPHARMA AD (the “Company") hereby informs that between 29 August 2012 and 05 September 2012, including, the Company bought back 18746 own shares representing 0.0142% of the share capital of the Company, at a total value of BGN 45675.09 on the Bulgarian Stock Exchange. The average price per share was BGN 2.44.

The shares have been bought on the basis of the decision of the General Meeting of Shareholders from 23 June 2010.

The intention of the Company is to use the repurchased shares in the future for compensating shareholders of companies, which will be merged into the Company.

The total number of treasury stocks after these transactions is 3204805, representing 2.43% of the share capital of the Company.
Annexes
File Description
Current report 88 buy back 10092012 ENG.doc Current report 88 buy back 10092012 ENG.doc Current report 88 buy back 10092012 ENG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-09-10 Ognian Donev Executive Director